Quotient Sciences Acquires Arcinova

Read the press release here

The expertise of the next generation and the implementation of flow chemistry in pharma

Our Head of Drug Substance, Paul Quigley, shared his insights into how the next generation of scientists are using their skills and knowledge to help bridge the gap in expertise between batch and flow technologies. In this Chemistry Today article, Paul explains how pharmaceutical companies can encourage more flow chemistry researchers to consider careers in industry. Read the article here

 




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH